Sedative and antinociceptive effects of different combinations of detomidine and methadone in standing horses.

The study explores the combination of two drugs, detomidine and methadone, administered intravenously in horses, with the aim of providing pain relief and sedation without associated adverse effects.

Experimental Design

• The research involved eight healthy, adult horses, aged around 7 years and weighing roughly 372 kg.
• The study was conducted as a randomized, blinded, placebo-controlled crossover trial.
• The team administered six different treatments intravenously: saline as a placebo, detomidine alone, methadone alone, and three different combinations of methadone with detomidine, varying by dosage.

Measurements and Methods

• Nociceptive thresholds (pain response levels) were assessed using thermal, mechanical, and electrical stimuli.
• The evaluation also included the degree of sedation, head height above ground (as a measure of sedation), cardiopulmonary variables, and intestinal motility.
• These measures were taken at various intervals, ranging from 5 minutes to 180 minutes post-administration
• Statistical analysis was carried out using mixed-model analysis of variance for normal data and the Kruskal-Wallis test for non-normal distributions.

Key Findings

• The combination of methadone and higher doses of detomidine led to a more significant and longer-lasting increase in pain threshold than lower doses or the individual drugs.
• However, no such increases in pain threshold were recorded with the saline placebo or methadone alone.
• Head height above the ground, reflecting sedation, was lower for longer durations with the higher doses of detomidine combined with methadone.
• Intestinal motility was reduced for longer periods in the treatment involving the highest dose of detomidine.
• No apparent sedation was recorded with the saline placebo, methadone alone, or the lowest dosage of the methadone-detomidine combination.

Conclusions

• It was observed that a specific dosage of methadone (0.2 mg kg) potentiated the pain-relieving effects of detomidine (5 μg kg), with only minimal sedative effects.
• The same dosage of detomidine, when combined with methadone, provided pain relief without the adverse effects associated with higher doses of detomidine.